Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: A proof-of-concept study-Reference-Cited by-同舟云学术

Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: A proof-of-concept study

Published:2016-01-14 Issue:1 Volume:64 Page:189-199
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Hirschfield Gideon M.¹,Gershwin M. Eric²,Strauss Richard³,Mayo Marlyn J.⁴,Levy Cynthia⁵,Zou Bin³,Johanns Jewel³,Nnane Ivo P.³,Dasgupta Bidisha³,Li Katherine³,Selmi Carlo⁶⁷,Marschall Hanns-Ulrich⁸,Jones David⁹,Lindor Keith¹⁰,

Affiliation:

1. National Institute of Health Research (NIHR) Biomedical Research Unit (BRU) and Center for Liver Research; University of Birmingham; Birmingham United Kingdom

2. Division of Rheumatology, Allergy & Immunology; The University of California School of Medicine; Davis CA

3. Janssen Research & Development, LLC; Spring House PA

4. University of Texas Southwestern, Dallas; TX

5. University of Miami; Miami FL

6. Division of Rheumatology and Clinical Immunology; Humanitas Clinical and Research Center; Milan Italy

7. BIOMETRA Department; University of Milan; Milan Italy

8. Sahlgrenska Academy, Institute of Medicine, Department of Molecular and Clinical Medicine; University of Gothenburg; Gothenburg Sweden

9. Institute of Cellular Medicine; University of Newcastle; Newcastle Upon Tyne United Kingdom

10. Arizona State University; Phoenix AZ

Funder

Janssen Pharmaceutical Research and Development, LLC

Publisher